Press Resease

Vitamin D Therapy Market - By Route of Administration (Oral and Parenteral), by Purchasing Pattern (OTC Drugs and Prescription Drugs), by Application (Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders, and Others), by Age Group (Children, Adults, and Senior Adults), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 04-Sep-2019 Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-4666 Status : Published

Global Vitamin D Therapy market accrued revenue worth nearly 2 (USD Billion) in 2019 and record a CAGR of about 11.7 % over the period from 2020 to 2026.

Description

The global Vitamin D Therapy market accrued revenue worth nearly 2 (USD Billion) in 2019 and record a CAGR of about 11.7 % over the period from 2020 to 2026. The report offers assessment and analysis of the Vitamin D Therapy market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Introduction

Vitamin D, which is a kind of lipophilic vitamin,  comprises of a cluster of fat-soluble seco-sterols and is identified as rapidly soluble prohormone that aids in controlling of phosphate & calcium metabolism.  Two types of vitamins are available in market and are referred to as vitamin D2 and vitamin D3. Vitamin D2 is generally made by humans and fortified with diet. It is found in mushrooms and has plant source. In case of D3, it is synthesized in the skin of humans from 7-dehydrocholesterol and can also be availed via the intake of animal-based diets including cod-liver oil, egg yolk, and meat of fatty fish. A key aspect of vitamin D is that it can be synthesized by the human body with the help of sun rays.

Furthermore, food supplements comprising of vitamin D are consumed more frequently across the globe in the recent times. Vitamin D used in supplement products are either in the form of vitamin D2 or vitamin D3.  Moreover, Vitamin D supplements are also available commercially in form of oily drops, tablets, and capsules.

Details of the Report:

Report Metric

Details

Base Year

2019

Historical Data

2017 and 2018

Forecast period

2020-2026

Market Representation

Earnings provided in terms of USD Billion and CAGR estimated from 2020 to 2026

Segments Analyzed

By Route of Administration, By Purchasing Pattern, By Application, By Age Group,  and By Region

Regions Analyzed

North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa

Market Growth Drivers

Vitamin D deficiency results in lack of the bone mineralization leading to various disorders in adults such as bone fractures, osteomalacia, and osteoporosis. Additionally, it can also treat hyperparathyroidism in adults. Hence, Vitamin D treatment helps in avoiding occurrence of these aforementioned diseases in adults. Apart from this, the product has also been utilized for preventing rickets in the children. This will unlock new growth avenues for the market over the years ahead.

Apparently, it has been found that calcitriol -an active Vitamin D Route of Administration- helps in controlling manifold cellular processes including normal & malignant cell proliferation. It also assists in regulating heart and immune functions in the humans.  As per NCBI, clinical research has proved the significance of vitamin D in prevention of cancer.  It has also been found that vitamin D therapy has benefited patients affected due to ailments such as diabetes, autoimmune disorders, psoriasis, and heart disease. Moreover, vitamin D treatment has proved to be beneficial for people having impaired skeletal disorders. Apparently, vitamin D is delivered in humans through drug delivery systems, food fortification, or dietary supplements for treating both non-skeletal as well as skeletal disorders. All these aforementioned factors are expected to chart a profitable growth graph for the vitamin D therapy market in the near future as well as for the next decade.

Furthermore, older persons who intake inadequate proportion of vitamin D in diet, low  exposure to sun, diminished dermal conversion of 7-dehydrocholesterol to vitamin D3, and secondary hyperparathyroidism are at prone to suffer from  poor bone health as well as  osteoporotic fractures. This will further drive the market growth over the forecast timespan.

According to Lancet, vitamin D deficiency is one of the key causes of death across various countries. Reportedly, the observations made in the study published in the journal state that out of twenty European countries, the average vitamin D proportion is low in the inhabitants of Italy and Spain. Moreover, it has been confirmed that these nations have observed high coronavirus deaths in comparison to the number of deaths witnessed in north European countries where high vitamin D proportions are found in the persons due to intake of cod liver oil as well as vitamin D supplements. This has proved that Vitamin D can enhance the immunity of individuals against CoVID-19 to a larger extent. This will expand the scope of vitamin D therapy market over the coming years.

According to WHO, Vitamin D plays the role of immunomodulation,  enhancing immune system  and boosting mucosal defenses to offer protection to the human body from infection and cancer. Furthermore, it also helps in prevention of respiratory tract ailments.

Asia Pacific to dominate the overall market growth during 2020-2026

The regional market growth over the forecast period is owing to high percentage of vitamin D insufficiency witnessed in nearly over 70.1% population in the countries like India. According to NCBI, Vitamin D deficiency is projected to play a pivotal role in the huge occurrence of diseases such as rickets, cancer, cardiovascular diseases, osteoporosis, diabetes, and tuberculosis in the country.

In addition to this, NIH researchers have observed that widely consumed food items such as dairy products sold in India are rarely fortified with vitamin D. Additionally, low exposure to sunlight is expected to influence the demand for vitamin D treatment in the country. Furthermore, large percentage of Indian population intake vegetarian food and studies have revealed that proportion of Vitamin D is less in vegetarian diet as the high fiber content & large proportion of phytate present in the vegetarian reduce the absorption of vitamin D. This will generate huge demand for vitamin D treatment in the country, thereby embellishing the regional market trends over the next couple of years.

Moreover, the inadequacy of Vitamin D witnessed in the Asian countries has created huge health issues, thereby generating humongous demand for functional foods fortified with vitamin D during food processing in the region. This will generate huge market demand within the span of next few years.

Key players profiled in the report include Novartis International AG, Torrent Pharmaceuticals Ltd., Abbott, Merck & Co., Inc., Sanofi, Cadila Healthcare Ltd., Pfizer, Inc., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd.

The report segments the global vitamin D therapy market as follows:

By Route of Administration

  • Oral
  • Parenteral

By Purchasing Pattern

  • OTC Drugs
  • Prescription Drugs

By Application

  • Osteoporosis
  • Rickets
  • Skin Diseases
  • Muscle Weakness
  • Autoimmune Disorders
  • Others

By Age Group

  • Children
  • Adults
  • Senior Adults

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Vitamin D Therapy Market, 2016–2026(USD Billion)
    • 2.2. Vitamin D Therapy Market: Snapshot
  • Chapter 3. Global Vitamin D Therapy Market– Industry Analysis
    • 3.1. Vitamin D Therapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing need for preventing rickets, bone fracture, and secondary hyperparathyroidism will drive the market trends
      • 3.2.2. Massive demand for strengthening the immune system to prevent diabetes, autoimmune disorders, psoriasis, and heart disease will steer the business growth
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Route of Administration
      • 3.4.2. Market attractiveness analysis By Purchasing Pattern
      • 3.4.3. Market attractiveness analysis By Application
      • 3.4.4. Market attractiveness analysis By Age Group
  • Chapter 4. Global Vitamin D Therapy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Vitamin D Therapy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Vitamin D Therapy Market–Route of Administration Analysis
    • 5.1. Global Vitamin D Therapy Market overview: By Route of Administration
      • 5.1.1. Global Vitamin D Therapy Market share, By Route of Administration,2019 and 2026
    • 5.2. Oral
      • 5.2.1. Global Vitamin D Therapy Market by Oral, 2016–2026(USD Billion)
    • 5.3. Parenteral
      • 5.3.1. Global Vitamin D Therapy Market by Parenteral, 2016–2026(USD Billion)
  • Chapter 6. Global Vitamin D Therapy Market–Purchasing Pattern Analysis
    • 6.1. Global Vitamin D Therapy Market overview: By Purchasing Pattern
      • 6.1.1. Global Vitamin D Therapy Market share, By Purchasing Pattern,2019 and 2026
    • 6.2. OTC Drugs
      • 6.2.1. Global Vitamin D Therapy Market by OTC Drugs, 2016–2026(USD Billion)
    • 6.3. Prescription Drugs
      • 6.3.1. Global Vitamin D Therapy Market by Prescription Drugs, 2016–2026(USD Billion)
  • Chapter 7. Global Vitamin D Therapy Market– Application Analysis
    • 7.1. Global Vitamin D Therapy Market overview: By Application
      • 7.1.1. Global Vitamin D Therapy Market share, By Application, 2019 and 2026
    • 7.2. Osteoporosis
      • 7.2.1. Global Vitamin D Therapy Market By Osteoporosis, 2016–2026(USD Billion)
    • 7.3. Rickets
      • 7.3.1. Global Vitamin D Therapy Market By Rickets, 2016–2026(USD Billion)
    • 7.4. Skin Diseases
      • 7.4.1. Global Vitamin D Therapy Market By Skin Diseases, 2016–2026(USD Billion)
    • 7.5. Muscle Weakness
      • 7.5.1. Global Vitamin D Therapy Market By Muscle Weakness, 2016–2026(USD Billion)
    • 7.6. Autoimmune Disorders
      • 7.6.1. Global Vitamin D Therapy Market By Autoimmune Disorders, 2016–2026(USD Billion)
    • 7.7. Others
      • 7.7.1. Global Vitamin D Therapy Market By Others, 2016–2026(USD Billion)
  • Chapter 8. Global Vitamin D Therapy Market– Age Group Analysis
    • 8.1. Global Vitamin D Therapy Market overview: By Age Group
      • 8.1.1. Global Vitamin D Therapy Market share, By Age Group, 2019 and 2026
    • 8.2. Children
      • 8.2.1. Global Vitamin D Therapy Market By Children, 2016–2026(USD Billion)
    • 8.3. Adults
      • 8.3.1. Global Vitamin D Therapy Market By Adults, 2016–2026(USD Billion)
    • 8.4. Senior Adults
      • 8.4.1. Global Vitamin D Therapy Market By Senior Adults, 2016–2026(USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Novartis International AG
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Torrent Pharmaceuticals Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Abbott
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Merck & Co., Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Sanofi
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Cadila Healthcare Ltd.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Pfizer, Inc.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Merck & Co., Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Sun Pharmaceutical Industries Ltd.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development

Methodology


Frequently Asked Questions

The key growth drivers that will leverage the market growth include massive need of vitamin D therapy for preventing the diseases like rickets, bone fractures, osteomalacia, and osteoporosis in children & adults

The CAGR of the industry is expected to be nearly 11.7 % during the forecast timespan.

Asia Pacific region will contribute remarkably towards the global market share over the estimated timeline.

The key market participants include Novartis International AG, Torrent Pharmaceuticals Ltd., Abbott, Merck & Co., Inc., Sanofi, Cadila Healthcare Ltd., Pfizer, Inc., Merck & Co., Inc., and Sun Pharmaceutical Industries Ltd.

 

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social